{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:58:29Z","timestamp":1761217109644},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s11936-001-0041-6","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T08:11:34Z","timestamp":1180858294000},"page":"225-235","source":"Crossref","is-referenced-by-count":6,"title":["Prophylaxis of venous thrombosis"],"prefix":"10.1007","volume":"3","author":[{"given":"Samuel Z.","family":"Goldhaber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1378\/chest.118.6.1680","volume":"118","author":"SZ Goldhaber","year":"2000","unstructured":"Goldhaber SZ, Dunn K, MacCougall RC: New onset of venous thromboembolism among hospitalized patients at Brigham and Women\u2019s Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000, 118:1680\u20131684.","journal-title":"Chest"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005373-199907000-00006","volume":"47","author":"CG Elliott","year":"1999","unstructured":"Elliott CG, Dudney TM, Egger M, et al.: Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma. J Trauma 1999, 47:25\u201332.","journal-title":"J Trauma"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1302\/0301-620X.81B4.9464","volume":"81","author":"J Blanchard","year":"1999","unstructured":"Blanchard J, Meuwly JY, Leyvraz PF, et al.: Prevention of deep-vein thrombosis after total knee replacement. J Bone Joint Surg Br 1999, 81:654\u2013659.","journal-title":"J Bone Joint Surg Br"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archinte.158.14.1525","volume":"158","author":"RH White","year":"1998","unstructured":"White RH, Romano PS, Zhou H, et al.: Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998, 158:1525\u20131531.","journal-title":"Arch Intern Med"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/archinte.160.14.2199","volume":"160","author":"RD Hull","year":"2000","unstructured":"Hull RD, Pineo GF, Francis C, et al.: Low-molecularweight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med 2000, 160:2199\u20132207.","journal-title":"Arch Intern Med"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/archinte.160.14.2208","volume":"160","author":"RD Hull","year":"2000","unstructured":"Hull RD, Pineo GF, Francis C, et al.: Low-molecularweight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin\/out-ofhospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med 2000, 160:2208\u20132215.","journal-title":"Arch Intern Med"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archinte.158.1.47","volume":"158","author":"C Demers","year":"1998","unstructured":"Demers C, Marcoux S, Ginsberg JS, et al.: Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 1998, 158:47\u201350.","journal-title":"Arch Intern Med"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1008915202859","volume":"8","author":"AT Chan","year":"1999","unstructured":"Chan AT, Atiemo A, Diran LK, et al.: Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis 1999, 8:139\u2013142.","journal-title":"J Thromb Thrombolysis"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199807093390204","volume":"339","author":"G Agnelli","year":"1998","unstructured":"Agnelli G, Piovella F, Buoncristiani P, et al.: Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 1998, 339:80\u201385.","journal-title":"N Engl J Med"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00006123-199811000-00039","volume":"43","author":"LD Dickinson","year":"1998","unstructured":"Dickinson LD, Miller LD, Patel CP, Gupta SK: Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery 1998, 43:1074\u20131081.","journal-title":"Neurosurgery"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-96-5-561","volume":"96","author":"H Halkin","year":"1982","unstructured":"Halkin H, Goldberg J, Modan M, Modan B: Reduction of mortality in general medical in-patients by lowdose heparin prophylaxis. Ann Intern Med 1982, 96:561\u2013564.","journal-title":"Ann Intern Med"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.1995.03530040063042","volume":"274","author":"DR Hirsch","year":"1995","unstructured":"Hirsch DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995, 274:335\u2013337.","journal-title":"JAMA"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","volume":"341","author":"MM Samama","year":"1999","unstructured":"Samama MM, Cohen T, Darmon JV, et al.: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999, 341:793\u2013800. The only contemporary large-scale trial of venous thromboembolism prophylaxis among medical patients. The results justify the use of enoxaparin, 40 mg daily, for prophylaxis.","journal-title":"N Engl J Med"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1613749","volume":"83","author":"P Mismetti","year":"2000","unstructured":"Mismetti P, Laporte-Simitsidis S, Tardy B, et al.: Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecularweight heparins: a meta-analysis of randomized clinical trials. Thromb Haemost 2000, 83:14\u201319.","journal-title":"Thromb Haemost"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"81","author":"BJ Sanson","year":"1999","unstructured":"Sanson BJ, Lensing AW, Prins MH, et al.: Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999, 81:668\u2013672.","journal-title":"Thromb Haemost"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1001\/archinte.160.18.2741","volume":"160","author":"JM Teich","year":"2000","unstructured":"Teich JM, Merchia PR, Schmiz JL, et al.: Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000, 160:2741\u20132747.","journal-title":"Arch Intern Med"},{"key":"41_CR17","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1001\/jama.283.21.2816","volume":"283","author":"P Durieux","year":"2000","unstructured":"Durieux P, Nizard R, Ravaud P, et al.: A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000, 283:2816\u20132821. A Parisian orthopedic service takes the lead in encouraging physicians to implement established guidelines to prevent venous thromboembolism by using a computer-based clinical decision support system. This system helped to change physician behavior and improved compliance.","journal-title":"JAMA"},{"key":"41_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00001721-199606000-00002","volume":"7","author":"CM Kessler","year":"1996","unstructured":"Kessler CM, Hirsch DR, Jacobs H, et al.: Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis 1996, 7:437\u2013446.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000658-199709000-00010","volume":"226","author":"AJ Comerota","year":"1997","unstructured":"Comerota AJ, Chouhan V, Harada RN, et al.: The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997, 226:306\u2013313.","journal-title":"Ann Surg"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","volume":"338","author":"H Decousus","year":"1998","unstructured":"Decousus H, Leizorovicz A, Parent F, et al.: A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998, 338:409\u2013415. A multicenter randomized controlled trial by French investigators found that in high risk patients with proximal deep vein thrombosis, the initial benefit of filters for preventing pulmonary embolism was counterbalanced by a doubling of the rate of recurrent deep vein thrombosis.","journal-title":"N Engl J Med"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiology.216.1.r00jl1254","volume":"216","author":"CA Athanasoulis","year":"2000","unstructured":"Athanasoulis CA, Kaufman JA, Halpern EF, et al.: Inferior vena caval filters: review of a 26-year singlecenter clinical experience. Radiology 2000, 216:54\u201366.","journal-title":"Radiology"},{"key":"41_CR22","doi-asserted-by":"crossref","unstructured":"Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An International Multicentre Trial. Lancet 1975, 2:45\u201351.","DOI":"10.1016\/S0140-6736(75)90494-8"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","volume":"318","author":"R Collins","year":"1988","unstructured":"Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988, 318:1162\u20131173.","journal-title":"N Engl J Med"},{"key":"41_CR24","first-page":"211","volume-title":"Heparin-Induced Thrombocytopenia","author":"TE Warkentin","year":"2000","unstructured":"Warkentin TE, Greinacher A: Laboratory testing for heparin-induced thrombocytopenia. In Heparin-Induced Thrombocytopenia. Edited by Warkentin TE, Greinacher A. New York: Marcel Dekker, Inc; 2000:211\u2013244. Although minidose heparin rarely causes bleeding, it can cause in 1% to 2% of patients a devastating heparin-induced thrombocytopenia with paradoxical thrombosis. This well written book provides a comprehensive overview of heparininduced thrombocytopenia."},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","volume":"337","author":"JI Weitz","year":"1997","unstructured":"Weitz JI: Low-molecular weight heparins. N Engl J Med 1997, 337:688\u2013698. An excellent review article.","journal-title":"N Engl J Med"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2106\/00004623-199907000-00005","volume":"81","author":"CW Colwell Jr","year":"1999","unstructured":"Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, et al.: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999, 81:932\u2013940.","journal-title":"J Bone Joint Surg Am"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-124-7-199604010-00001","volume":"124","author":"JR Leclerc","year":"1996","unstructured":"Leclerc JR, Geerts WH, Desjardins L, et al.: Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 1996, 124:619\u2013626.","journal-title":"Ann Intern Med"},{"key":"41_CR28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/01.CIR.93.1.80","volume":"93","author":"M Gent","year":"1996","unstructured":"Gent M, Hirsh J, Ginsberg JS, et al.: Low-molecularweight heparinoid Orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation 1996, 93:80\u201384.","journal-title":"Circulation"},{"key":"41_CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1649626","volume":"70","author":"HN Magnani","year":"1993","unstructured":"Magnani HN: Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993, 70:554\u2013561.","journal-title":"Thromb Haemost"},{"key":"41_CR30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration: Collaborative overview of randomized trials of antiplatelet therapy-III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994, 308:235\u2013246.","journal-title":"BMJ"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","volume":"355","author":"Pulmonary Embolism Prevention (PEP) Trial Collaborative Group","year":"2000","unstructured":"Pulmonary Embolism Prevention (PEP) Trial Collaborative Group: Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000, 355:1295\u20131302.","journal-title":"Lancet"},{"key":"41_CR32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM199711063371901","volume":"337","author":"BI Eriksson","year":"1997","unstructured":"Eriksson BI, Wille-Jorgensen P, Kalebo P, et al.: A comparison of recombinant hirudin with a lowmolecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997, 337:1329\u20131335.","journal-title":"N Engl J Med"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-001-0041-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0041-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:37:32Z","timestamp":1587577052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-001-0041-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s11936-001-0041-6","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}